A novel composition comprises a compound of Formula 1
##STR1##
the pharmaceutically acceptable salts, hydrates, solvates, crystal forms, diastereomers,
prodrugs, or mixtures thereof. The composition is of particular utility in the
treatment of kinase-implicated disorders.
